Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
EXFY Quote, Financials, Valuation and Earnings
Last price:
$2.13
Seasonality move
:
-18.94%
Day range:
$2.08 - $2.21
52-week range:
$1.45 - $4.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.34x
P/B ratio:
1.46x
Volume:
917.9K
Avg. volume:
936.1K
1-year change:
2.4%
Market cap:
$196.8M
Revenue:
$139.2M
EPS (TTM):
-$0.09
Analysts' Opinion
-
Consensus RatingExpensify has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.00, Expensify has an estimated upside of 87.79% from its current price of $2.13.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing 100% downside risk from its current price of $2.13.
Fair Value
-
According to the consensus of 5 analysts, Expensify has 87.79% upside to fair value with a price target of $4.00 per share.
EXFY vs. S&P 500
-
Over the past 5 trading days, Expensify has underperformed the S&P 500 by -10.56% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Expensify does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Expensify has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Expensify reported revenues of $36.1M.
Earnings Growth
-
Expensify has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Expensify reported earnings per share of -$0.03.
Enterprise value:
137.2M
EV / Invested capital:
--
Price / LTM sales:
1.34x
EV / EBIT:
--
EV / Revenue:
0.97x
PEG ratio (5yr expected):
-1.10x
EV / Free cash flow:
6.89x
Price / Operating cash flow:
9.52x
Enterprise value / EBITDA:
20.00x
Gross Profit (TTM):
$74.3M
Return On Assets:
-5.15%
Net Income Margin (TTM):
-6.66%
Return On Equity:
-7.83%
Return On Invested Capital:
-7.28%
Operating Margin:
-4.12%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $169.2M | $144.1M | $141.8M | $33.5M | $36.1M | |
| Gross Profit | $104.9M | $78.4M | $74.3M | $19M | $18.2M | |
| Operating Income | -$13.1M | -$32.2M | -$515K | -$1.8M | -$1.5M | |
| EBITDA | -$7.5M | -$27.1M | $6.9M | -$370K | $496K | |
| Diluted EPS | -$0.31 | -$0.48 | -$0.09 | -$0.04 | -$0.03 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $174.2M | $194.1M | $143.2M | $153.7M | |
| Total Assets | -- | $198.8M | $217.3M | $184.8M | $189.2M | |
| Current Liabilities | -- | $61.1M | $61.9M | $70.3M | $47.3M | |
| Total Liabilities | -- | $114.3M | $114.6M | $78.3M | $54.6M | |
| Total Equity | -- | $84.5M | $102.7M | $106.5M | $134.7M | |
| Total Debt | -- | $67.4M | $66.8M | $22.6M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $29.3M | -$2.6M | $25.2M | $3.5M | $4.8M | |
| Cash From Investing | -$2.4M | -$9.2M | -$5.3M | -$2.8M | -$498K | |
| Cash From Financing | -$8.4M | -$44.6M | -$21.7M | $845K | $1.2M | |
| Free Cash Flow | $26.9M | -$11.8M | $19.9M | $642K | $4.3M | |
EXFY
Sector
Market Cap
$196.8M
$83.5M
Price % of 52-Week High
51.57%
64.2%
Dividend Yield
0%
0%
Shareholder Yield
0.62%
0.68%
1-Year Price Total Return
2.4%
-12.88%
Beta (5-Year)
--
0.814
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.30
200-day SMA
Sell
Level
$2.85
Bollinger Bands (100)
Sell
Level
2.3 - 3.22
Chaikin Money Flow
Sell
Level
-2.1M
20-day SMA
Sell
Level
$2.39
Relative Strength Index (RSI14)
Sell
Level
36.03
ADX Line
Sell
Level
35.9
Williams %R
Buy
Level
-90.2655
50-day SMA
Sell
Level
$2.39
MACD (12, 26)
Buy
Level
0.60
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Sell
Level
-3.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.2956)
Buy
CA Score
(Annual)
Level (0.5299)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.7302)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.
Stock Forecast FAQ
In the current month, EXFY has received 2 Buy ratings 3 Hold ratings, and 0 Sell ratings. The EXFY average analyst price target in the past 3 months is $4.00.
-
Where Will Expensify Stock Be In 1 Year?
According to analysts, the consensus estimate is that Expensify share price will rise to $4.00 per share over the next 12 months.
-
What Do Analysts Say About Expensify?
Analysts are divided on their view about Expensify share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Expensify is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is Expensify's Price Target?
The price target for Expensify over the next 1-year time period is forecast to be $4.00 according to 5 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is EXFY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Expensify is a Hold. 3 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EXFY?
You can purchase shares of Expensify via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Expensify shares.
-
What Is The Expensify Share Price Today?
Expensify was last trading at $2.13 per share. This represents the most recent stock quote for Expensify. Yesterday, Expensify closed at $2.13 per share.
-
How To Buy Expensify Stock Online?
In order to purchase Expensify stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
